Two systems, one patient

Australian pharmacists got prescribing authority. The clinical record did not follow.

Posted 10 August 2026 · By a Qiri staff contributor · 7 min read

A pharmacist in Brisbane sees a woman with a suspected urinary tract infection. She takes a history, works through the red flags, checks the exclusion criteria, prescribes, counsels her on what to watch for and when to see a doctor instead, and writes the consultation up.

Then she turns to the other screen and dispenses it.

Two systems. One patient. Half the story in each, and no single place that holds both halves.

That is not a workflow complaint. It is what happens when a profession is handed a new job and keeps the old filing cabinet.

The authority arrived faster than the plumbing

Five years ago, pharmacist prescribing in Australia was a position paper. Today it is business as usual across three states.

In Queensland, the Community Pharmacy Scope of Practice Pilot worked well enough that the government made pharmacist prescribing for a range of acute conditions a permanent feature of the health system. The acute common condition services, hormonal contraception service, medicines management services and health and wellbeing services moved from pilot status to business-as-usual community pharmacy services on 1 July 2025.¹ The three chronic condition programs, covering cardiovascular disease risk reduction, COPD, and asthma symptom control, ran on under pilot conditions until 30 June 2026.²

In Victoria, every stream of the Community Pharmacy Statewide Pilot became permanent, including treatment of urinary tract infections, skin conditions, ongoing hormonal contraception, and travel health vaccination, with the state funding the consultation so the patient pays nothing out of pocket.³

In New South Wales, the UTI and oral contraceptive trial had delivered more than 18,000 treatments when the Health Minister announced that community pharmacists would move to full scope of practice, adding acute conditions from reflux and allergic rhinitis to wound management and musculoskeletal pain for pharmacists who complete the accredited training.⁴

This is the fastest expansion of pharmacist responsibility in a generation. The training kept up. The clinical protocols kept up. The record did not.

If you are about to add a service line, the first question is not which training package to buy. It is where the clinical note will live, who can read it, and how you get it back out in five years.

Queensland did not stumble into two systems. It specified them.

Read the participation requirements and the split is there in black and white. Pharmacy owners had to demonstrate that the specified Pilot Clinical Information System was installed on a computer in the consultation room. Clinical records had to be maintained inside that system. Prescriptions for pilot services had to be generated from it. Any paper record made during a consultation had to be entered and then appropriately destroyed.² MedAdvisor won the competitive tender to deliver an enhanced version of its PlusOne platform as the clinical information system behind the pilot.⁵

Every one of those requirements is defensible. A health department rolling out prescribing authority to thousands of practitioners needs a consistent clinical record and consistent evaluation data, and it was never going to get either out of a dozen dispensing systems architected in the 1990s that have no field for a consultation. Specifying the clinical system was the fastest safe path to a rollout, and the rollout worked.

The second-order effect is what stuck. The supply record lives in the dispensing system. The clinical record lives somewhere else. The patient exists in both and is joined in neither.

Pick one patient who has had both a consultation and a dispense at your store in the last month, and time how long it takes to assemble the complete picture from both systems. Whatever that number is, it is the real cost of the split, and you pay it again every time somebody asks.

What a dispense record cannot tell you

A dispense record is a supply record, and it is very good at being one. Drug, form, strength, quantity, directions, date, prescriber, dispensing pharmacist, a unique reference number. Two decades of regulatory refinement have made it precise.

A prescribing record is a different object entirely. To be worth anything later it has to carry:

• What the patient presented with, in something close to their own words.
• What you asked, and what they answered.
• What you excluded, and on what basis. The referral criteria you worked through and did not meet.
• Why this medicine and not the alternative that was also reasonable.
• What you told them to watch for, and the point at which they should stop waiting and see a doctor.
• What happened if they came back.

Almost none of that has a home in a dispensing system, because a dispensing system was built on the assumption that somebody else did the diagnosing and the pharmacist was checking their work. For a growing share of the day, that assumption is no longer true.

So the clinical reasoning goes into a free-text box in a second system, or into the pharmacist's memory, or nowhere at all. The most valuable thing a pharmacy can standardise this month is the exclusion. Most consultation notes are written for what was found. The ones that hold up years later are written for what was ruled out.

The regulator is already reading the record

When something goes wrong, the file is the pharmacist.

In 2023/24, 466 notifications were made about 372 pharmacists, approximately 1.7% of the profession, a rate that has changed little across five years. Medications were by a wide margin the most common subject, at almost 60%. Communication came a distant second at around 9%.⁶

The usual outcome is that the Board takes no further regulatory action, or the pharmacist addresses the concern through education or a change of process.⁶ What does the work of getting there is a contemporaneous record showing that a competent practitioner considered the right things at the time. Where no such record exists, the pharmacist reconstructs their reasoning from memory, months or years later, about a consultation that took eleven minutes on a Thursday afternoon between a Webster pack and a delivery run.

Expanded scope moves more clinical reasoning onto the pharmacist. It has to move more of that reasoning onto the page as well, and the page has to be one page.

Sharing by default moves the record out of the building

A record that is hard to assemble internally becomes a much bigger problem once other clinicians expect to read it as a matter of course.

The Health Legislation Amendment (Modernising My Health Record, Sharing by Default) Act 2025 received Royal Assent on 14 February 2025 and establishes the framework for key health information to be shared to My Health Record by default rather than on request.⁷ Pathology and diagnostic imaging are named first. On 5 June 2026 the Department of Health, Disability and Ageing opened consultation on making medicines-related information the next category, beginning with providers who prescribe and dispense solely through telehealth and digital platforms, and covering Schedule 4 to Schedule 8 medicines. That consultation closed on 7 July 2026, with requirements to be finalised by the end of 2026 and commencement in 2027.⁸

Services combining face-to-face and online care sit outside that first tranche. Read the direction of travel anyway. The policy assumption has changed: medicines information is now something you share unless there is a reason not to. A pharmacy whose clinical reasoning lives in a consultation system that does not speak to its dispensing system will find that assumption expensive to satisfy. Put the question to both vendors in writing now: what do you upload to My Health Record today, and what will you upload in 2027?

The economics do not forgive a slow note

The Eighth Community Pharmacy Agreement runs from 1 July 2024 to 30 June 2029, with a total funding envelope of approximately $26.5 billion, a 22% increase on the 7CPA, including a substantial uplift in program funding for services such as MedsCheck, Dose Administration Aids and Staged Supply.⁹

That is real money for clinical work, and it is reshaping where a pharmacy's revenue comes from. What it does not change is the arithmetic inside a single consultation. Service fees are paid per consultation, not per minute. Every minute of duplicate entry, every retyped medicine name, every hunt for last month's note in the other system, comes directly out of the margin on that consultation. There are only so many consultation minutes in a day when the same pharmacist is also carrying the dispensing queue.

The profession has been funded to do more clinical work. It has not been funded to do the same clinical work twice. If the average consultation is eleven minutes of patient time and six minutes of typing, the six is the number to attack.

What one record actually looks like

The fix is not a better consultation form. It is refusing the split in the first place.

One record per patient, holding both the supply and the reasoning behind it, so the question "what happened with this patient" has exactly one answer and one place to find it.

Reasoning captured as structure, not prose. What was considered, what was excluded and why, which rules fired, which sources were cited, what the pharmacist decided. Written as the consultation happens rather than reconstructed from memory afterwards, because a trace written at the time is evidence and a trace written later is recollection.

The pharmacist as the decision-maker of record, always. Qiri prepares, reasons, and documents. The licensed pharmacist reviews, decides, and signs. The Pharmacy Board of Australia is unambiguous that the pharmacist holds independent professional responsibility for the decision,¹⁰ and we treat that as a design requirement rather than a constraint to engineer around.

A record built to be read by someone else. The GP down the road next Tuesday, the indemnity insurer in three years, My Health Record in 2027, and the regulator if it ever comes to that.

Expanded scope was the right reform, and Australia got there faster than most comparable health systems. The pharmacists doing the work have earned the trust that came with it. The gap was never clinical capability. We handed a profession a new kind of responsibility and left them recording it in software built for a different job.

Two systems and one patient is a solvable problem. It is just nobody's product yet.

We have written previously about what the bench is carrying¹¹ and why the software underneath it never got rebuilt.¹² This is the same argument one layer up. Every figure in this article is footnoted to its source, and our full methodology sits at qiri.ai/sources. If you run expanded-scope services in an Australian community pharmacy and have a view on exactly where the record breaks, we want to hear it. The Journal is open to letters and counter-arguments, and if you would rather talk it through, reach us here.